tirzepatide information sheet Dosage Guide and Chart for Weight Loss Users of Zepbound or Mounjaro

A once-weekly injectable glucose-dependent insulinotropic polypeptide/GLP-1 dual agonist conferred up to 14.7% weight loss at 13 weeks for adults with overweight or obesity, according to findings from the VENTURE trial published in Obesity

CURBS UNHEALTHY CRAVINGS: Apart from lowering overall blood glucose levels, Cinnamon enhances levels of leptin a hormone secreted by adipose tissue which controls food intake, decreasing appetite

Nevertheless, GLP-1RA therapy is associated with a pattern of adverse ...

Getting Enough Protein Protein helps support muscle maintenance, recovery, and overall health

Timing your tirzepatide injection can influence how your body responds to treatment and manages appetite signals